Overview

A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight

Status:
COMPLETED

Trial end date:
2024-11-22

Target enrollment:

Participant gender:

Summary

This research study tests if CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight. Participant will either get CagriSema (active medicine) or placebo (a dummy medicine), which has no effect on the body. The treatment participants get is decided by chance. The study will last for about 32 weeks.

Phase:

PHASE1

Details

Lead Sponsor:

Novo Nordisk A/S

Treatments:

cagrilintide
semaglutide